Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
Open Access
- 8 May 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (5) , 679
Abstract
ABCA1 and ABCG1 are two ABC-transporters well-recognized to promote the efflux of cholesterol to apoAI and HDL, respectively. As these two ABC-transporters are critical to cholesterol metabolism, several studies have assessed the impact of ABCA1 and ABCG1 expression on cellular cholesterol homeostasis through ABC-transporter ablation or overexpressing ABCA1/ABCG1. However, for the latter, there are currently no well-established in vitro models to effectively induce long-term ABC-transporter expression in a variety of cultured cells. Therefore, we performed proof-of-principle in vitro studies to determine whether a LoxP-Stop-LoxP (LSL) system would provide Cre-inducible ABC-transporter expression. In our studies, we transfected HEK293 cells and the HEK293-derived cell line 293-Cre cells with ABCA1-LSL and ABCG1-LSL-based plasmids. Our results showed that while the ABCA1/ABCG1 protein expression was absent in the transfected HEK293 cells, the ABCA1 and ABCG1 protein expression was detected in the 293-Cre cells transfected with ABCA1-LSL and ABCG1-LSL, respectively. When we measured cholesterol efflux in transfected 293-Cre cells, we observed an enhanced apoAI-mediated cholesterol efflux in 293-Cre cells overexpressing ABCA1, and an HDL2-mediated cholesterol efflux in 293-Cre cells constitutively expressing ABCG1. We also observed an appreciable increase in HDL3-mediated cholesterol efflux in ABCA1-overexpressing 293-Cre cells, which suggests that ABCA1 is capable of effluxing cholesterol to small HDL particles. Our proof-of-concept experiments demonstrate that the LSL-system can be used to effectively regulate ABC-transporter expression in vitro, which, in turn, allows ABCA1/ABCG1-overexpression to be extensively studied at the cellular level.Keywords
Funding Information
- American Heart Association (20AIREA35120024, 1021291, P20GM109094)
- USDA National Institute of Food and Agriculture, Hatch project SC-1700577 (20AIREA35120024, 1021291, P20GM109094)
- Clemson University Division of Research (20AIREA35120024, 1021291, P20GM109094)
- NIH Eukaryotic Pathogens Innovation Center, Centers of Biomedical Research Excellence (20AIREA35120024, 1021291, P20GM109094)
This publication has 74 references indexed in Scilit:
- The Role of Chromatin in Adenoviral Vector FunctionViruses, 2013
- Gene Overexpression: Uses, Mechanisms, and InterpretationGenetics, 2012
- Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosisJournal of Lipid Research, 2012
- Mammalian cell transfection: the present and the futureAnalytical and Bioanalytical Chemistry, 2010
- Targeted Deletion of Hepatocyte ABCA1 Leads to Very Low Density Lipoprotein Triglyceride Overproduction and Low Density Lipoprotein HypercatabolismJournal of Biological Chemistry, 2010
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of MacrophagesJournal of Biological Chemistry, 2008
- Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in miceJournal of Clinical Investigation, 2007
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJournal of Clinical Investigation, 2007
- The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type IBiochemical Journal, 2007